Dysglycemia and Index60 as Prediagnostic End Points for Type 1 Diabetes Prevention Trials

Dysglycemia and Index60 as Prediagnostic End Points for Type 1 Diabetes Prevention Trials

This item appears in the following Collection(s)

Available in accordance with the Publisher Policy. Please refer to the publisher's site for terms of use.

Search Repository


My Account

Statistics